Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rumex Vesicarius L. extract improves the efficacy of doxorubicin in triple-negative breast cancer through inhibiting Bcl2, mTOR, JNK1 and augmenting p21 expression
Aml Ghanem, Ahmed A. Al‐Karmalawy, Ahmed I. Abd El Maksoud, et al.
Informatics in Medicine Unlocked (2022) Vol. 29, pp. 100869-100869
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Design, synthesis, and SAR studies of novel 4-methoxyphenyl pyrazole and pyrimidine derivatives as potential dual tyrosine kinase inhibitors targeting both EGFR and VEGFR-2
Abeer M. El‐Naggar, A.M.A. Hassan, Eslam B. Elkaeed, et al.
Bioorganic Chemistry (2022) Vol. 123, pp. 105770-105770
Closed Access | Times Cited: 77
Emerging biomarkers and potential therapeutics of the BCL-2 protein family: the apoptotic and anti-apoptotic context
Md. Saddam, Shamrat Kumar Paul, Mohammad Ahsan Habib, et al.
Egyptian Journal of Medical Human Genetics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 22
Synthesis, structural characterization, DFT calculations, molecular docking, and molecular dynamics simulations of a novel ferrocene derivative to unravel its potential antitumor activity
Mohamed M. Hammoud, Muhammad Khattab, Marwa Abdel‐Motaal, et al.
Journal of Biomolecular Structure and Dynamics (2022), pp. 1-18
Open Access | Times Cited: 52
Ligand-Based Design on the Dog-Bone-Shaped BIBR1532 Pharmacophoric Features and Synthesis of Novel Analogues as Promising Telomerase Inhibitors with In Vitro and In Vivo Evaluations
Ahmed A. Al‐Karmalawy, Mohamed S. Nafie, Moataz A. Shaldam, et al.
Journal of Medicinal Chemistry (2022) Vol. 66, Iss. 1, pp. 777-792
Closed Access | Times Cited: 43
Anticoagulants as Potential SARS-CoV-2 Mpro Inhibitors for COVID-19 Patients: In Vitro, Molecular Docking, Molecular Dynamics, DFT, and SAR Studies
Ayman Abo Elmaaty, Wagdy M. Eldehna, Muhammad Khattab, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 20, pp. 12235-12235
Open Access | Times Cited: 42
Design and synthesis of novel benzoazoninone derivatives as potential CBSIs and apoptotic inducers: In Vitro, in Vivo, molecular docking, molecular dynamics, and SAR studies
Mohamed M. Hammouda, Ayman Abo Elmaaty, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2022) Vol. 127, pp. 105995-105995
Closed Access | Times Cited: 41
A Systematic Review of the Global Intervention for SARS-CoV-2 Combating: From Drugs Repurposing to Molnupiravir Approval
Nada A. Ashour, Ayman Abo Elmaaty, Amany A. Sarhan, et al.
Drug Design Development and Therapy (2022) Vol. Volume 16, pp. 685-715
Open Access | Times Cited: 40
Ligand-based design and synthesis of N'-Benzylidene-3,4-dimethoxybenzohydrazide derivatives as potential antimicrobial agents; evaluation by in vitro, in vivo, and in silico approaches with SAR studies
Rogy R. Ezz Eldin, Marwa A. Saleh, Mohammad Hayal Alotaibi, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 1098-1119
Open Access | Times Cited: 37
A novel role of Nano selenium and sildenafil on streptozotocin-induced diabetic nephropathy in rats by modulation of inflammatory, oxidative, and apoptotic pathways
Mona F. El-Azab, Ahmed A. Al‐Karmalawy, Samar A. Antar, et al.
Life Sciences (2022) Vol. 303, pp. 120691-120691
Closed Access | Times Cited: 37
Design, synthesis, biological evaluation, and SAR studies of novel cyclopentaquinoline derivatives as DNA intercalators, topoisomerase II inhibitors, and apoptotic inducers
Mohamed M. Hammoud, Alaa S. Nageeb, M.A. Morsi, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 23, pp. 11422-11436
Closed Access | Times Cited: 35
Ligand-based design, synthesis, computational insights, andin vitrostudies of novelN-(5-Nitrothiazol-2-yl)-carboxamido derivatives as potent inhibitors of SARS-CoV-2 main protease
Mohamed Elagawany, Ayman Abo Elmaaty, Ahmed Mostafa, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 37, Iss. 1, pp. 2112-2132
Open Access | Times Cited: 35
Biological evaluation, docking studies, and in silico ADME prediction of some pyrimidine and pyridine derivatives as potential EGFR WT and EGFR T790M inhibitors
Tarfah Al‐Warhi, Ahmed A. Al‐Karmalawy, Ayman Abo Elmaaty, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2022) Vol. 38, Iss. 1, pp. 176-191
Open Access | Times Cited: 29
Rumex vesicarius L. boosts the effectiveness of sorafenib in triple-negative breast cancer by downregulating BCl2, mTOR, and JNK, and upregulating p21 expression
Aml Ghanem, Mohamed A. Ali, Mohamed A. Elkady, et al.
Pathology - Research and Practice (2023) Vol. 250, pp. 154807-154807
Closed Access | Times Cited: 19
Design and synthesis of novel quinazolinone–chalcone hybrids as potential apoptotic candidates targeting caspase-3 and PARP-1:in vitro, molecular docking, and SAR studies
Eman A. Madbouly, El‐Sayed M. Lashine, Ahmed A. Al‐Karmalawy, et al.
New Journal of Chemistry (2022) Vol. 46, Iss. 46, pp. 22013-22029
Closed Access | Times Cited: 20
Thieno[2,3-b]thiophene Derivatives as Potential EGFRWT and EGFRT790M Inhibitors with Antioxidant Activities: Microwave-Assisted Synthesis and Quantitative In Vitro and In Silico Studies
Sanaa A. Ahmed, Moumen S. Kamel, Moustafa O. Aboelez, et al.
ACS Omega (2022) Vol. 7, Iss. 49, pp. 45535-45544
Open Access | Times Cited: 19
Unveiling the anticancer potential and toxicity of Ganoderma applanatum wild mushroom derived bioactive compounds: An in vitro, in vivo and in silico evaluation
Akbar Rijia, Raman Krishnamoorthi, Pambayan Ulagan Mahalingam, et al.
Bioorganic Chemistry (2025) Vol. 156, pp. 108233-108233
Closed Access
Experimental design of D-α-tocopherol polyethylene glycol 1000 succinate stabilized bile salt based Nano-vesicles for improved cytotoxicity and bioavailability of colchicine binding site inhibitor Candidates: In Vitro, in silico, and pharmacokinetic studies
Ayman Abo Elmaaty, Ahmed A. Al‐Karmalawy, Mohamed S. Nafie, et al.
International Journal of Pharmaceutics (2023) Vol. 640, pp. 122980-122980
Closed Access | Times Cited: 9
Preparation of antioxidant-biodegradable poly(acrylic acid-co-2-hydroxyethyl methacrylate) hydrogel using rutin as a crosslinker: Drug release and anticancer activity
Ferah Cömert Önder, Alper Önder, Pınar Ilgın, et al.
Reactive and Functional Polymers (2023) Vol. 190, pp. 105650-105650
Closed Access | Times Cited: 8
A Novel Aniline Derivative from Peganum harmala L. Promoted Apoptosis via Activating PI3K/AKT/mTOR-Mediated Autophagy in Non-Small Cell Lung Cancer Cells
Zhongnan Wu, Wen Li, Qing Tang, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 16, pp. 12626-12626
Open Access | Times Cited: 7
The combined effect of zinc oxide nanoparticles and milrinone on acute renal ischemia/reperfusion injury in rats: Potential underlying mechanisms
Eman M. Embaby, Rasha M. Saleh, Basma H. Marghani, et al.
Life Sciences (2023) Vol. 323, pp. 121435-121435
Closed Access | Times Cited: 6
Computational Design, Synthesis, and Bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide Derivatives: Dual Inhibition of EGFRWT and EGFRT790M with ADMET Profiling
Nilesh Raghunath Khedkar, Milind Sindkhedkar, Alex Joseph
Bioorganic Chemistry (2023) Vol. 143, pp. 107027-107027
Closed Access | Times Cited: 6
Phytochemical Characterization of Pterocephalus frutescens with In-Silico Evaluation as Chemotherapeutic Medicine and Oral Pharmacokinetics Prediction Study
Atef A. El‐Hela, Marwa S. Abu Bakr, Mostafa M. Hegazy, et al.
Scientia Pharmaceutica (2023) Vol. 91, Iss. 1, pp. 7-7
Open Access | Times Cited: 4
Hyaluronic Acid-Engineered Bcl-2 Inhibitor Nanocrystals for Site-Specific Delivery to Breast Tumor Cells
Dilip Panwar, Pradip Thakor, Madhu Sharma, et al.
Nanomedicine (2023) Vol. 18, Iss. 15, pp. 1005-1023
Closed Access | Times Cited: 3
Emerging Biomarkers and Potential Therapeutics of the BCL-2 Protein Family: The Apoptotic and Anti-Apoptotic Context
Shamrat Kumar Paul, Md. Saddam, Mohammad Ahsan Habib, et al.
(2023)
Open Access | Times Cited: 2
Synthesis and spectroscopic study of novel mixed ligand formula “Artemisinin/Zn” and assessment of its inhibitory effect against “SARS-CoV-2″
Fawziah A. Al‐Salmi, Samy M. El‐Megharbel, Reham Z. Hamza
Heliyon (2023) Vol. 9, Iss. 6, pp. e17177-e17177
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top